Home LiteratureArticle Details
PMID: 20439758 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli.

Moriel DG, Bertoldi I, Spagnuolo A, Marchi S, Rosini R, Nesta B, Pastorello I, Corea VA, Torricelli G, Cartocci E, Savino S, Scarselli M, Dobrindt U, Hacker J, Tettelin H, Tallon LJ, Sullivan S, Wieler LH, Ewers C, Pickard D, Dougan G, Fontana MR, Rappuoli R, Pizza M, Serino L

Abstract

Extraintestinal pathogenic Escherichia coli (ExPEC) are a common cause of disease in both mammals and birds. A vaccine to prevent such infections would be desirable given the increasing antibiotic resistance of these bacteria. We have determined the genome sequence of ExPEC IHE3034 (ST95) isolated from a case of neonatal meningitis and compared this to available genome sequences of other ExPEC strains and a few nonpathogenic E. coli. We found 19 genomic islands present in the genome of IHE3034, which are absent in the nonpathogenic E. coli isolates. By using subtractive reverse vaccinology we identified 230 antigens present in ExPEC but absent (or present with low similarity) in nonpathogenic strains. Nine antigens were protective in a mouse challenge model. Some of them were also present in other pathogenic non-ExPEC strains, suggesting that a broadly protective E. coli vaccine may be possible. The gene encoding the most protective antigen was detected in most of the E. coli isolates, highly conserved in sequence and found to be exported by a type II secretion system which seems to be nonfunctional in nonpathogenic strains.

MeSH Terms
Animals Antigens, Bacterial/genetics Base Sequence Computational Biology Escherichia coli/genetics,immunology Escherichia coli Infections/prevention & control Escherichia coli Vaccines/genetics Finland Genome, Bacterial/genetics Genomic Islands/genetics Humans Meningitis, Escherichia coli/microbiology Mice Molecular Sequence Data Secretory Pathway/genetics Sequence Analysis, DNA
Chemicals
Antigens, Bacterial Escherichia coli Vaccines
Authors & Affiliations
25 authors, click to expand affiliations / ORCID
Moriel Danilo Gomes
Novartis Vaccines and Diagnostics, 53100 Siena, Italy.
Bertoldi Isabella
Spagnuolo Angela
Marchi Sara
Rosini Roberto
Nesta Barbara
Pastorello Ilaria
Corea Vanja A Mariani
Torricelli Giulia
Cartocci Elena
Savino Silvana
Scarselli Maria
Dobrindt Ulrich
Hacker Jörg
Tettelin Hervé
Tallon Luke J
Sullivan Steven
Wieler Lothar H
Ewers Christa
Pickard Derek
Dougan Gordon
Fontana Maria Rita
Rappuoli Rino
Pizza Mariagrazia
Serino Laura
References (54)
54 references, click to expand
  1. Activation of prophage eib genes for immunoglobulin-binding proteins by genes from the IbrAB genetic island of Escherichia coli ECOR-9.
    J Bacteriol. 2002 Jul;184(13):3640-8 PMID: 12057959
  2. Type II secretion: a protein secretion system for all seasons.
    Trends Microbiol. 2005 Dec;13(12):581-8 PMID: 16216510
  3. Further characterization of Escherichia coli brain microvascular endothelial cell invasion gene ibeA by deletion, complementation, and protein expression.
    J Infect Dis. 2001 Apr 1;183(7):1071-8 PMID: 11237832
  4. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach.
    Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5977-82 PMID: 16585510
  5. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
    J Urol. 2004 Apr;171(4):1682-5 PMID: 15017266
  6. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract.
    Infect Immun. 2007 Jul;75(7):3233-44 PMID: 17420234
  7. Subtractive hybridization and optical mapping of the enterotoxigenic Escherichia coli H10407 chromosome: isolation of unique sequences and demonstration of significant similarity to the chromosome of E. coli K-12.
    Microbiology (Reading). 2006 Apr;152(Pt 4):1041-1054 PMID: 16549668
  8. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli.
    J Bacteriol. 2007 May;189(9):3532-46 PMID: 17351047
  9. Identification and characterization of a novel ABC iron transport system, fit, in Escherichia coli.
    Infect Immun. 2006 Dec;74(12):6949-56 PMID: 16982838
  10. Contribution of the SitABCD, MntH, and FeoB metal transporters to the virulence of avian pathogenic Escherichia coli O78 strain chi7122.
    Infect Immun. 2008 Feb;76(2):601-11 PMID: 18025097
  11. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.
    Infect Immun. 1991 Mar;59(3):1153-61 PMID: 1671776
  12. Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development.
    Expert Rev Vaccines. 2006 Feb;5(1):45-54 PMID: 16451107
  13. Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536.
    Infect Immun. 2002 Nov;70(11):6365-72 PMID: 12379716
  14. Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections.
    Infect Immun. 2002 Sep;70(9):5335-7 PMID: 12183596
  15. Six widespread bacterial clones among Escherichia coli K1 isolates.
    Infect Immun. 1983 Jan;39(1):315-35 PMID: 6218094
  16. The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes.
    J Bacteriol. 2007 Apr;189(8):3228-36 PMID: 17293413
  17. The complete genome sequence of Escherichia coli K-12.
    Science. 1997 Sep 5;277(5331):1453-62 PMID: 9278503
  18. Expert system for predicting protein localization sites in gram-negative bacteria.
    Proteins. 1991;11(2):95-110 PMID: 1946347
  19. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
    Science. 2000 Mar 10;287(5459):1816-20 PMID: 10710308
  20. Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1.
    Infect Immun. 1985 Aug;49(2):365-70 PMID: 2410365
  21. Extensive gene diversity in septicemic Escherichia coli strains.
    J Clin Microbiol. 2005 Jan;43(1):66-73 PMID: 15634952
  22. Pathogenic Escherichia coli.
    Nat Rev Microbiol. 2004 Feb;2(2):123-40 PMID: 15040260
  23. Intestine and environment of the chicken as reservoirs for extraintestinal pathogenic Escherichia coli strains with zoonotic potential.
    Appl Environ Microbiol. 2009 Jan;75(1):184-92 PMID: 18997030
  24. IroN functions as a siderophore receptor and is a urovirulence factor in an extraintestinal pathogenic isolate of Escherichia coli.
    Infect Immun. 2002 Dec;70(12):7156-60 PMID: 12438401
  25. Cytolethal distending toxin: creating a gap in the cell cycle.
    J Med Microbiol. 2005 Mar;54(Pt 3):207-216 PMID: 15713603
  26. Biology of type II secretion.
    Mol Microbiol. 2001 Apr;40(2):271-83 PMID: 11309111
  27. Genomic fluidity and pathogenic bacteria: applications in diagnostics, epidemiology and intervention.
    Nat Rev Microbiol. 2008 May;6(5):387-94 PMID: 18392032
  28. Aspects of genome plasticity in pathogenic Escherichia coli.
    Int J Med Microbiol. 2007 Nov;297(7-8):625-39 PMID: 17462951
  29. Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization.
    Infect Immun. 1988 Nov;56(11):2822-9 PMID: 2902009
  30. Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant.
    Mol Cell Proteomics. 2008 Mar;7(3):473-85 PMID: 17982123
  31. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli.
    Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17939-44 PMID: 19815525
  32. Fate of the H-NS-repressed bgl operon in evolution of Escherichia coli.
    PLoS Genet. 2009 Mar;5(3):e1000405 PMID: 19266030
  33. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.
    Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12391-6 PMID: 12200547
  34. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.
    Vaccine. 2007 May 10;25(19):3859-70 PMID: 17306426
  35. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains.
    Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12879-84 PMID: 16912116
  36. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.
    Microbes Infect. 2003 Apr;5(5):449-56 PMID: 12738001
  37. Type VI secretion: a beginner's guide.
    Curr Opin Microbiol. 2008 Feb;11(1):3-8 PMID: 18289922
  38. PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis.
    Bioinformatics. 2005 Mar 1;21(5):617-23 PMID: 15501914
  39. Genome-based vaccine development: a short cut for the future.
    Hum Vaccin. 2008 May-Jun;4(3):184-8 PMID: 20686357
  40. GenomeViz: visualizing microbial genomes.
    BMC Bioinformatics. 2004 Dec 15;5:198 PMID: 15601465
  41. Involvement of Escherichia coli K1 ibeT in bacterial adhesion that is associated with the entry into human brain microvascular endothelial cells.
    Med Microbiol Immunol. 2008 Dec;197(4):337-44 PMID: 18040715
  42. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths.
    PLoS Genet. 2009 Jan;5(1):e1000344 PMID: 19165319
  43. The E. coli alpha-hemolysin secretion system and its use in vaccine development.
    Trends Microbiol. 2002 Jan;10(1):39-45 PMID: 11755084
  44. Sex and virulence in Escherichia coli: an evolutionary perspective.
    Mol Microbiol. 2006 Jun;60(5):1136-51 PMID: 16689791
  45. The enterohemolysin phenotype of bovine Shiga-like toxin-producing Escherichia coli (SLTEC) is encoded by the EHEC-hemolysin gene.
    Vet Microbiol. 1996 Sep;52(1-2):153-64 PMID: 8914259
  46. Mucosal immunization with iron receptor antigens protects against urinary tract infection.
    PLoS Pathog. 2009 Sep;5(9):e1000586 PMID: 19806177
  47. S-Fimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia coli strain 536.
    Infect Immun. 2001 Jul;69(7):4248-56 PMID: 11401961
  48. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Science. 1997 Apr 25;276(5312):607-11 PMID: 9110982
  49. Signature-tagged mutagenesis in a chicken infection model leads to the identification of a novel avian pathogenic Escherichia coli fimbrial adhesin.
    PLoS One. 2009 Nov 12;4(11):e7796 PMID: 19907658
  50. Extraintestinal pathogenic isolates of Escherichia coli do not possess active IgA1, IgA2, sIgA or IgG proteases.
    FEMS Immunol Med Microbiol. 2008 Jun;53(1):65-71 PMID: 18384367
  51. Escherichia coli induces DNA double-strand breaks in eukaryotic cells.
    Science. 2006 Aug 11;313(5788):848-51 PMID: 16902142
  52. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.
    Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4 PMID: 12471157
  53. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli.
    Infect Immun. 2007 Apr;75(4):1916-25 PMID: 17145948
  54. The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate.
    Infect Immun. 2003 Dec;71(12):7164-9 PMID: 14638809
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2010-05-18
Epub
2010-00-03
Pages
9072-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2889118
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com